Dr. Martens (LON:DOCS) Trading Down 7.4% – What’s Next?

Dr. Martens plc (LON:DOCS) was down 7.4% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 75.58. Approximately 2,918,600 shares traded hands during mid-day trading, an increase of 33% from the average daily volume of 2,195,955 shares. The stock had previously closed at GBX 81.60.

Wall Street Analyst Weigh In

Separately, Peel Hunt raised shares of Dr. Martens to a “buy” rating in a research report on Monday, August 18th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of GBX 6,000.

Dr. Martens Trading Down 10.2%

The business has a 50 day moving average price of GBX 90.64 and a 200-day moving average price of GBX 80.35. The firm has a market cap of £707.96 million, a price-to-earnings ratio of 146.53, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS) last issued its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Ije Nwokori sold 298,675 shares of the business’s stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson bought 105,838 shares of the business’s stock in a transaction dated Monday, September 1st. The stock was bought at an average price of GBX 91 per share, for a total transaction of £96,312.58. Over the last quarter, insiders have acquired 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. Corporate insiders own 2.80% of the company’s stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.